EGFR Positive UK made the following post on X:
“Study finds liquid biopsies are as reliable as tissue biopsies for lung cancer pts with EGFR mutations, but far less invasive, making it easier to monitor & tailor treatments effectively. This is a big step forward in improving the care & QOL for patients.”
Luis E. Raez, Medical Director at Memorial Cancer Institute, retweeted this post, adding the following:
“These are great news! several of us have shown before that we can use liquid biopsies first
to make treatment decisions faster for our patients.”
Read further.
Source: EGFR Positive UK/X and Luis E. Raez/X